Washington, November 17 (RHC)-- U.S. President Donald Trump has nominated Alex Azar, a former top executive of pharmaceutical giant Eli Lilly, to lead the Department of Health and Human Services. The post has been vacant since the resignation of Tom Price.
Public Citizen’s Robert Weissman criticized the nomination, saying: “Tom Price supported Big Pharma in the U.S. Congress. Now apparently Trump has decided to cut out the middleman and let a pharmaceutical executive literally run the federal department that protects the health of all Americans.”
Donald Trump Nominates Former Drug Company Executive as HHS Secretary
Facebook
Twitter
Pinterest
Telegram
Linkedin
WhatsApp
Matérias relacionadas
Comentários
Deixe um comentário
Todos os campos são requeridos
Mais vistas
- Governo de Milei tensiona as relações entre Argentina e Chile
- Petro anuncia novo processo de paz com gangues colombianas
- Díaz-Canel agradece grito unânime de Cuba contra o bloqueio dos EUA
- Governo equatoriano diz que apagão nacional foi causado por vandalismo
- Cartunistas de Cuba e Argentina ganham evento de humor gráfico
